Related Experiment Video
Updated: Sep 10, 2025

11:11
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
16.9K
Clinical Assessment of Next-Generation Sequencing Probe Reproducibility in Short-Read Sequencing (ClinRay) Using
Rohan Gnanaolivu1, Neiladri Saha1, Noemi Vidal-Folch2
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
The Journal of Molecular Diagnostics : JMD
|August 27, 2025
Summary
ClinRay enhances variant detection in challenging genomic regions using short-read sequencing. This bioinformatics tool improves reproducibility by creating synthetic data, aiding clinical diagnostics.
Area of Science:
- Genomics
- Bioinformatics
- Clinical Diagnostics
Background:
- Short-read next-generation sequencing (NGS) is crucial for clinical diagnosis but struggles with variant detection in complex genomic regions.
- These regions, including segmental duplications and repeat sequences, impact variant detection reproducibility.
- Current validation methods are costly and time-consuming, delaying clinical results.
Purpose of the Study:
- To develop a novel bioinformatics method, ClinRay, to predict variant detection reproducibility in difficult-to-sequence genomic regions.
- To address the limitations of short-read NGS in complex genomic areas.
- To improve the accuracy and efficiency of variant detection for clinical applications.
Main Methods:
- ClinRay utilizes a "digital twin" approach to synthetically enhance data for regions with suspected poor reproducibility.
- The model was trained using alignment data from eight replicates of the Genome in a Bottle HG002 cell line.
- Publicly available genomic context annotation resources were integrated into the model development.
Main Results:
- ClinRay achieved an area under the receiver-operating characteristic curve (AUC) of 0.89 (95% CI, 0.88-0.90) on test data.
- The model demonstrated strong performance on an independent validation dataset with an AUC of 0.85 (95% CI, 0.84-0.86).
- ClinRay effectively predicts the reproducibility of variants detected by short-read NGS probes.
Conclusions:
- ClinRay offers a generalizable bioinformatics solution for improving variant detection reproducibility in challenging genomic regions.
- The method has the potential to reduce costs and turnaround times in clinical laboratories.
- ClinRay enhances the reliability of short-read NGS for clinical variant interpretation.
Related Concept Videos
Next-generation Sequencing
92.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.6K
RNA-seq
10.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.4K

